Type of Oral Anticoagulant and Adverse Clinical Outcomes in Patients Extending Anticoagulation Therapy Beyond 90 Days After Hospitalization for VTE

To the Editor We have several concerns about the recent study1 that demonstrated no significant difference in major bleeding with extended-duration direct oral anticoagulant (DOAC) therapy beyond 90 days after initial discharge for venous thromboembolism (VTE).